Home

Screener

BPMC

Profile

BPMC Stock Price History and Quote Analysis: Insights for Investors

Blueprint Medicines Corporation

(NASDAQ:BPMC)

$69.12

0.67 (0.98%)

At Close: 4:00 PM

BPMC Stock Price Graph

BPMC Stock Price Today

Blueprint Medicines Corporation (BPMC) stock rallied over 0.98% intraday to trade at $69.12 a share on NASDAQ. The stock opened with a loss of -16.85% at $56.91 and touched an intraday high of $57.48, rising 0.98% against the last close of $68.45. The Blueprint Medicines Corporation in stock market went to a low of $53.13 during the session.

BPMC Stock Snapshot

$68.45

Prev. Close

4.2 Billion

Market Cap

$53.13

Day Low

$56.91

Open

N/A

Number of Shares

$57.48

Day High

N/A

P/E ratio

-9.20

EPS (TTM)

11.73

Cash Flow per Share

N/A

Free Float in %

3.34

Book Value

736851.00

Volume

BPMC Stock Price History Chart

Date	Open	High	Low	Close	Volume

Contact Details

45 Sidney Street
Cambridge, MA 02139
US

Website:https://www.blueprintmedicines.com

Contact #:617 374 7580

About Company

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Peers

Frequently Asked Questions

What is the current Blueprint Medicines Corporation (BPMC) stock price?

Blueprint Medicines Corporation (NASDAQ: BPMC) stock price is $69.12 in the last trading session. During the trading session, BPMC stock reached the peak price of $57.48 while $53.13 was the lowest point it dropped to. The percentage change in BPMC stock occurred in the recent session was 0.98% while the dollar amount for the price change in BPMC stock was $0.67.

BPMC's industry and sector of operation?

The NASDAQ listed BPMC is part of Biotechnology industry that operates in the broader Healthcare sector. Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma.

Who are the executives of BPMC?

Ms. Tracey L. McCain Esq.
Executive Vice President, Chief Legal & Compliance Officer and Sec.
Mr. Jeffrey W. Albers J.D., M.B.A., MBA
Executive Chairman
Ms. Kathryn Haviland
Pres, Chief Executive Officer & Director
Dr. Christopher K. Murray
Senior Vice President of Technical Operations

How BPMC did perform over past 52-week?

BPMC's closing price is 0.54% higher than its 52-week low of $37.82 where as its distance from 52-week high of $68 is -0.26%.

How many employees does BPMC have?

Number of BPMC employees currently stands at N/A. BPMC operates from 45 Sidney Street, Cambridge, MA 02139, US.

Link for BPMC official website?

Official Website of BPMC is: https://www.blueprintmedicines.com

How do I contact BPMC?

BPMC could be contacted at phone #617 374 7580 and can also be accessed through its website. BPMC operates from 45 Sidney Street, Cambridge, MA 02139, US.

How many shares of BPMC are traded daily?

BPMC stock volume for the day was 736851.00 shares. The average number of BPMC shares traded daily for last 3 months was 633.1 Thousands.

What is the market cap of BPMC currently?

The market value of BPMC currently stands at $4.2 Billion with its latest stock price at $69.12 and N/A of its shares outstanding.